Avance Biosciences, a leading CRO that provides GLP/CGMP-compliant biological testing services that aid drug development and manufacturing, announced that it has signed a licensing...
The Rare Disease Cures Accelerator-Data and Analytics Platform initiative (RDCA-DAP®) hosted an all-day workshop and annual meeting September 13 and 14 in Washington. The...
Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation,...
